Showing results (71-80 of 4,126) with videos related to
Sort By:
Pageof 413
Oncology Letters|April 29, 2016
EGFR-tyrosine kinase inhibitor treatment in a patient with advanced non-small cell lung cancer and concurrent exon 19 and 21 EGFR mutations: A case report and review of the literatureYang Yang, Biao Zhang, Rutian Li, et al.Cancer Letters|January 21, 2017
MHC class II restricted neoantigen: A promising target in tumor immunotherapyZhichen Sun, Fangjun Chen, Fanyan Meng, et al.Investigational New Drugs|February 10, 2023
A phase Ib/II study of BLU-554, a fibroblast growth factor receptor 4 inhibitor in combination with CS1001, an anti-PD-L1, in patients with locally advanced or metastatic hepatocellular carcinomaMingzhen Zhou, Sihui Zhu, Chen Xu, et al.Materials Today. Bio|December 1, 2025
Engineered nano-bacteria hybrids for precision cancer immunotherapyLiang Yu, Yulin Qiu, Baorui Liu, et al.BMC Cancer|November 9, 2016
Early evaluation of irradiated parotid glands with intravoxel incoherent motion MR imaging: correlation with dynamic contrast-enhanced MR imagingNan Zhou, Chen Chu, Xin Dou, et al.Journal of Biomedical Nanotechnology|July 30, 2019
Facile Optimization and Evaluation of PEG-PCL Block Copolymeric Nanoparticles for Anticancer Drug Delivery Using Copolymer Hybrids and Histoculture Drug Response AssaysRutian Li, Jing Yan, Li Xie, et al.Oncotarget|October 21, 2017
Apparent diffusion coefficient histogram analysis can evaluate radiation-induced parotid damage and predict late xerostomia degree in nasopharyngeal carcinomaNan Zhou, Tingting Guo, Huanhuan Zheng, et al.Nature Communications|January 6, 2015
Hypoxia-specific ultrasensitive detection of tumours and cancer cells in vivoXianchuang Zheng, Xin Wang, Hui Mao, et al.Oncology Reports|April 2, 2016
Coupling Gd‑DTPA with a bispecific, recombinant protein anti‑EGFR‑iRGD complex improves tumor targeting in MRIXiaoyan Xin, Huizi Sha, Jingtao Shen, et al.Expert Review of Anticancer Therapy|April 28, 2017
The role of adhesions between homologous cancer cells in tumor progression and targeted therapyJie Xia, Yuhao Cheng, Hang Zhang, et al.Pageof 413